기관회원 [로그인]
소속기관에서 받은 아이디, 비밀번호를 입력해 주세요.
개인회원 [로그인]

비회원 구매시 입력하신 핸드폰번호를 입력해 주세요.
본인 인증 후 구매내역을 확인하실 수 있습니다.

회원가입
서지반출
Synthesis of Low Molecular Weight Alginic Acid Nanoparticles through Persulfate Treatment as Effective Drug Delivery System to Manage Drug Resistant Bacteria
[STEP1]서지반출 형식 선택
파일형식
@
서지도구
SNS
기타
[STEP2]서지반출 정보 선택
  • 제목
  • URL
돌아가기
확인
취소
  • Synthesis of Low Molecular Weight Alginic Acid Nanoparticles through Persulfate Treatment as Effective Drug Delivery System to Manage Drug Resistant Bacteria
  • Synthesis of Low Molecular Weight Alginic Acid Nanoparticles through Persulfate Treatment as Effective Drug Delivery System to Manage Drug Resistant Bacteria
저자명
Ghosh. Dipankar,Pramanik. Arindam,Sikdar. Narattam,Pramanik. Panchanan
간행물명
Biotechnology and bioprocess engineering
권/호정보
2011년|16권 2호|pp.383-392 (10 pages)
발행정보
한국생물공학회
파일정보
정기간행물|ENG|
PDF텍스트
주제분야
기타
이 논문은 한국과학기술정보연구원과 논문 연계를 통해 무료로 제공되는 원문입니다.
서지반출

기타언어초록

The purpose of this study was to prepare low molecular weight alginic acid (LMWA) nanoparticles by cation-induced, controlled gelification of depolymerized alginic acid for effective drug delivery to drug resistant bacteria. The depolymerization reaction was performed using potassium persulfate oxidation at an optimized condition. The optimized conditions for depolymerization were anticipated to be $37^{circ}C$, pH 4, 2 days reaction time, and a 0.075 M concentration of potassium persulphate containing 0.001 M silver nitrate in the final reaction mixture. Gel permeation chromatography showed depolymerized alginic acid had an average molecular weight of $20.95{pm}0.49$ kDa. Depolymerized alginic acid was also characterized for its structural integrity by X-ray diffraction, nuclear magnetic resonance, and Fourier transform spectroscopy. Depolymerized alginic acid was used to prepare low molecular weight nanoparticles with a particle size of $54{pm}0.41$ nm, and a zetapotential of $-32.2{pm}3.91$ mV. The nanoparicles were then subjected to tetracycline loading. In vitro drug loading and drug release efficiencies after 100 h were determined to be $66.56{pm}1.88$ and $61.8{pm}0.141%$, respectively. Finally, the minimal inhibitory concentration and a putative mode of action for the tetracycline nanoparticles were determined using tetracycline resistant bacteria, Escherichia coli XL-1.